Zai Lab (ZLAB) Change in Receivables (2020 - 2026)
Zai Lab (ZLAB) posted quarterly Change in Receivables of -$53.3 million for Q1 2026, down 509.68% year-on-year from $13.0 million in Q1 2025, and down 370.97% on a QoQ basis from $19.7 million in Q4 2025.
Zai Lab (ZLAB) Change in Receivables (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Change in Receivables for 7 consecutive years, with -$53.3 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Receivables fell 509.68% year-over-year to -$53.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.6 million (down 251.38% YoY) and the FY2025 annual result came in at $18.9 million, down 29.82% from the prior year.
- Change in Receivables fell to -$53.3 million in Q1 2026 per ZLAB's latest filing, from $19.7 million in the prior quarter.
- Over the last five years, Change in Receivables for ZLAB reached as high as $36.7 million in Q4 2024 and fell as low as -$53.3 million in Q1 2026.
- A 5-year average of $491117.6 and a median of $2.9 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 194.78% — and 2025, when it slumped 757.91%.
- Year by year, Change in Receivables stood at $12.2 million in 2022, then soared by 41.67% to $17.2 million in 2023, then surged by 113.09% to $36.7 million in 2024, then slumped by 46.42% to $19.7 million in 2025, then slumped by 370.97% to -$53.3 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$53.3 million, $19.7 million, and -$3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -53.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.27 Mn |
| Mar 31, 2026 | -53.27 Mn |
| Dec 31, 2025 | 19.66 Mn |
| Dec 31, 2025 | 19.66 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 11.68 Mn |
| Jun 30, 2025 | 11.68 Mn |
| Mar 31, 2025 | -8.74 Mn |
| Mar 31, 2025 | -8.74 Mn |
| Dec 31, 2024 | 36.69 Mn |
| Dec 31, 2024 | 36.69 Mn |
| Sep 30, 2024 | -20.55 Mn |
| Sep 30, 2024 | -20.55 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Dec 31, 2023 | 17.22 Mn |